About methyl 2-[4-[3-[N'-(2-chloro-5-fluorophenyl)carbamimidoyl]-4-(cyclohexylamino)pyrrolo[1,2-b]pyridazin-6-yl]-3-methylphenoxy]acetate
methyl 2-[4-[3-[N'-(2-chloro-5-fluorophenyl)carbamimidoyl]-4-(cyclohexylamino)pyrrolo[1,2-b]pyridazin-6-yl]-3-methylphenoxy]acetate (PubChem CID 163374937) has the molecular formula C30H31ClFN5O3
and a molecular weight of 564.06 g/mol. Its IUPAC name is methyl 2-[4-[3-[N'-(2-chloro-5-fluorophenyl)carbamimidoyl]-4-(cyclohexylamino)pyrrolo[1,2-b]pyridazin-6-yl]-3-methylphenoxy]acetate.
Molecular Properties
| Compound Name | methyl 2-[4-[3-[N'-(2-chloro-5-fluorophenyl)carbamimidoyl]-4-(cyclohexylamino)pyrrolo[1,2-b]pyridazin-6-yl]-3-methylphenoxy]acetate |
| PubChem CID | 163374937 |
| Molecular Formula | C30H31ClFN5O3 |
| Molecular Weight | 564.06 g/mol |
| Exact Mass | 563.21 |
| IUPAC Name | methyl 2-[4-[3-[N'-(2-chloro-5-fluorophenyl)carbamimidoyl]-4-(cyclohexylamino)pyrrolo[1,2-b]pyridazin-6-yl]-3-methylphenoxy]acetate |
| SMILES | COC(=O)COc1ccc(-c2cc3c(NC4CCCCC4)c(/C(N)=N/c4cc(F)ccc4Cl)cnn3c2)c(C)c1 |
| InChI | InChI=1S/C30H31ClFN5O3/c1-18-12-22(40-17-28(38)39-2)9-10-23(18)19-13-27-29(35-21-6-4-3-5-7-21)24(15-34-37(27)16-19)30(33)36-26-14-20(32)8-11-25(26)31/h8-16,21,35H,3-7,17H2,1-2H3,(H2,33,36) |
| InChIKey | XUYRXBMDWUNMLD-UHFFFAOYSA-N |
| XLogP | 6.44 |
| TPSA | 103.24 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 40 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
| MW ≤ 500 | 564.06 |
| LogP ≤ 5 | 6.44 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 7 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'imine_2', 'substructure': 'N/A'} |
|---|
Analyze methyl 2-[4-[3-[N'-(2-chloro-5-fluorophenyl)carbamimidoyl]-4-(cyclohexylamino)pyrrolo[1,2-b]pyridazin-6-yl]-3-methylphenoxy]acetate with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of methyl 2-[4-[3-[N'-(2-chloro-5-fluorophenyl)carbamimidoyl]-4-(cyclohexylamino)pyrrolo[1,2-b]pyridazin-6-yl]-3-methylphenoxy]acetate?
The IUPAC name of methyl 2-[4-[3-[N'-(2-chloro-5-fluorophenyl)carbamimidoyl]-4-(cyclohexylamino)pyrrolo[1,2-b]pyridazin-6-yl]-3-methylphenoxy]acetate (CID 163374937) is methyl 2-[4-[3-[N'-(2-chloro-5-fluorophenyl)carbamimidoyl]-4-(cyclohexylamino)pyrrolo[1,2-b]pyridazin-6-yl]-3-methylphenoxy]acetate.
What is the SMILES notation for methyl 2-[4-[3-[N'-(2-chloro-5-fluorophenyl)carbamimidoyl]-4-(cyclohexylamino)pyrrolo[1,2-b]pyridazin-6-yl]-3-methylphenoxy]acetate?
The canonical SMILES for methyl 2-[4-[3-[N'-(2-chloro-5-fluorophenyl)carbamimidoyl]-4-(cyclohexylamino)pyrrolo[1,2-b]pyridazin-6-yl]-3-methylphenoxy]acetate is COC(=O)COc1ccc(-c2cc3c(NC4CCCCC4)c(/C(N)=N/c4cc(F)ccc4Cl)cnn3c2)c(C)c1.
What is the InChIKey of methyl 2-[4-[3-[N'-(2-chloro-5-fluorophenyl)carbamimidoyl]-4-(cyclohexylamino)pyrrolo[1,2-b]pyridazin-6-yl]-3-methylphenoxy]acetate?
The InChIKey is XUYRXBMDWUNMLD-UHFFFAOYSA-N. The full InChI is InChI=1S/C30H31ClFN5O3/c1-18-12-22(40-17-28(38)39-2)9-10-23(18)19-13-27-29(35-21-6-4-3-5-7-21)24(15-34-37(27)16-19)30(33)36-26-14-20(32)8-11-25(26)31/h8-16,21,35H,3-7,17H2,1-2H3,(H2,33,36).
What are the key properties of methyl 2-[4-[3-[N'-(2-chloro-5-fluorophenyl)carbamimidoyl]-4-(cyclohexylamino)pyrrolo[1,2-b]pyridazin-6-yl]-3-methylphenoxy]acetate?
methyl 2-[4-[3-[N'-(2-chloro-5-fluorophenyl)carbamimidoyl]-4-(cyclohexylamino)pyrrolo[1,2-b]pyridazin-6-yl]-3-methylphenoxy]acetate has a molecular weight of 564.06 g/mol, XLogP of 6.44, 8 rotatable bonds, 2 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for methyl 2-[4-[3-[N'-(2-chloro-5-fluorophenyl)carbamimidoyl]-4-(cyclohexylamino)pyrrolo[1,2-b]pyridazin-6-yl]-3-methylphenoxy]acetate is sourced from PubChem (CID 163374937), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).